We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Progress Volume: Modern Developments in Therapeutics and Methods of Treatment, to Accompany "An Integrated Practice of Medicine."

AMA Arch Intern Med. 1951;87(2):324-325. doi:10.1001/archinte.1951.03810020146017.
Text Size: A A A
Published online


This progress volume is full of useful information. Many tables summarize a large amount of material and are a good source of information when there is little time to search elsewhere. In the first part of the volume the various antigens used in diagnosis are listed, and one learns where one can obtain such skin testing agents as coccidioidin, which as yet is commercially unavailable. The therapeutic usefulness of aureomycin, chloramphenicol (chloromycetin®) and terramycin is well summarized, but, of course, individual observations do differ. The author places chloramphenicol ahead of a combination of streptomycin and sulfonamides in the treatment of Bacillus pyocyaneus infections.

In addition, there is a large quantity of useful laboratory material relative to the employment of various therapeutic agents. For example, the various methods of determining the coagulation time and the prothrombin time are outlined in a discussion on bishydroxycoumarin (dicumarol®) and heparin therapy.



Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.